Baxter International Aktie News

Baxter International gets its buy rating from December reaffirmed, agreeing with today's bullish consensus from SA analysts and Wall Street. Positive drivers of the bull call include recent Q4 performance, declining debt, innovative new products in the pipeline, and dividend growth. Some weak spots are an unremarkable dividend yield or future revenue growth vs peers, as well as the nature of le...

On February 8, 2024, Baxter International BAX Inc. (NYSE: BAX, $39.64, Market Capitalization: $20.1 billion), a global medtech leader, reported steady 4Q23 results, with a mild beat vs consensus on revenues and adjusted EPS. In 4Q23, consolidated revenue increased by 3.7% YoY to $3.9 billion (up 3% on a constant currency basis).

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced a major milestone by reaching its Interim Enrollment target of patient 90 in its TIGRIS trial.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on April 1, 2024, to stockholders of record as of March 1, 2024. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every da...

Baxter International Inc. (BAX) Q4 2023 Earnings Call Transcript

Baxter International beat Wall Street expectations for fourth-quarter sales and profit on Thursday on strong demand for its medical devices and improvements in the supply chain environment.

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2023, and provided its financial guidance for full-year and first-quarter 2024. “Baxter's performance in 2023 reflects our building momentum as we executed upon several strategic initiatives designed to enhance our future per...

MoneyShow presents top investment ideas for 2024 from their contributors. This year's edition presents a broad mix of conservative income stocks, more speculative but potentially more rewarding growth stocks, as well as ETF recommendations that target commodities, cryptocurrencies, and fixed income.